Multimodality Treatment of 15 Malignant WHO III (2007 Criteria) Meningiomas: Differential Survival Rates Between De Novo and Progressive Origins

Authors :: Maciej M. Mrugala
Lois Gonzalez-Cuyar
Joshua W. Osbun
Owais Ahmad
Manuel A. R. Ferreira
Jason K. Rockhill
Donald E. Born
Philip D. Tatman
Source :: Journal of Neurological Surgery Part B: Skull Base. 75
Publication Year :: 2014
Publisher :: Georg Thieme Verlag KG, 2014.

Subjects :: Oncology
medicine.medical_specialty
Pathology
business.industry
Multimodality Treatment
Internal medicine
medicine
Differential survival
Neurology (clinical)
business

Full Text Access

Tools